Maier, K-P <br/><br/>
[Drug therapy in chronic liver disease].  [electronic resource] 

 -  Praxis  Nov 2005 
 - 1907-12 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1661-8157 
<br/><br/><label>Standard No.: </label>10.1024/0369-8394.94.48.1907  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--administration & dosage<br/>Administration, Oral<br/>Anti-HIV Agents--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Azathioprine--administration & dosage<br/>Cholangitis, Sclerosing--drug therapy<br/>Chronic Disease<br/>Drug Therapy, Combination<br/>Fatty Liver--drug therapy<br/>Hemochromatosis--drug therapy<br/>Hepatitis B, Chronic--drug therapy<br/>Hepatitis C, Chronic--drug therapy<br/>Hepatitis, Autoimmune--drug therapy<br/>Hepatolenticular Degeneration--drug therapy<br/>Humans<br/>Immunosuppression Therapy<br/>Interferons--administration & dosage<br/>Lamivudine--administration & dosage<br/>Liver Cirrhosis, Biliary--drug therapy<br/>Liver Diseases--drug therapy<br/>Organophosphonates--administration & dosage<br/>Prednisolone--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Reverse Transcriptase Inhibitors--administration & dosage<br/>Ribavirin--administration & dosage<br/>Time Factors